Maven Securities’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-32,912
Closed -$3.03M 1339
2020
Q4
$3.03M Buy
32,912
+22,912
+229% +$1.93M 0.3% 80
2020
Q3
$754K Buy
+10,000
New +$635K 0.06% 304

Other funds holding CELL

Maven Securities's CELL Position: Q1 2021 in Review

Maven Securities sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2021, closing a stake of 32,912 shares — an estimated $3.03M sold.

Maven Securities first reported a position in CELL in Q3 2020 and held it in 2 quarters. The position peaked at $3.03M in Q4 2020. 155 funds tracked by Wall St. Rank hold CELL as of Q1 2021.

  • Maven Securities reported no remaining PhenomeX Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Maven Securities sold 32,912 PhenomeX Inc. Common Stock shares in Q1 2021, an estimated $3.03M.
  • Maven Securities first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Maven Securities's PhenomeX Inc. Common Stock position peaked at $3.03M in Q4 2020.
  • 155 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2021.

Based on Maven Securities's 13F filing for Q1 2021, filed 17 May 2021.